Tocilizumab for treating giant cell arteritis Tocilizumab (RoActemra) is available on the NHS as a possible treatment for giant cell arteritis in adults if: they have relapsing or refractory disease. they have not already had tocilizumab. tocilizumab is only given for 1 year at most.